Cubist Systematic Strategies, LLC Rocket Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $122,812 - $233,768	7,319 New	7,319 $219,000
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $1.94 Million - $2.89 Million	157,109 New	157,109 $2.51 Million
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $274,237 - $573,281	-34,452 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $244,223 - $439,453	-18,558 Reduced 35.01%	34,452 $546,000
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $1.1 Million - $1.84 Million	51,210 Added 2845.0%	53,010 $1.16 Million
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $141,542 - $252,783	-5,162 Reduced 74.15%	1,800 $54,000
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $537,985 - $645,009	-13,651 Reduced 66.23%	6,962 $308,000
Q1 2021 May 17, 2021	BUY	$43.34 - $65.91 $893,367 - $1.36 Million	20,613 New	20,613 $915,000
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $189,850 - $264,771	-9,261 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $123,356 - $209,391	9,261 New	9,261 $194,000
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $218,717 - $565,602	-22,525 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $249,351 - $545,780	22,525 New	22,525 $513,000

218

93.3M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $783M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.